†Values are reported only for those parameters used in
the deterministic sensitivity analyses. When only an upper or lower
value is reported indicates that an extreme-value univariate analysis
was conducted. ‡Indicates the amount of time under
treatment required to control symptoms associated to a moderate
exacerbation. The duration of a severe exacerbation results of adding
the duration of a moderate exacerbation with 3.2 days of length of stay
considered as the mean time for an asthma-related hospitalization.
DSA=Deterministic Sensitivity Analyses, ICS=Inhaled corticosteroids,
SCIT+ICS=Subcutaneous Immunotherapy and Inhaled corticosteroids,
GINA=Global Initiative for Asthma